# Discontinuation of Disease Modifying Therapies (DMTs) in Multiple Sclerosis (MS)

> **NCT03073603** · PHASE4 · COMPLETED · sponsor: **University of Colorado, Denver** · enrollment: 259 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** Discontinuation of disease modifying therapy
- **DRUG:** Standard of Care

## Key facts

- **NCT ID:** NCT03073603
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-20
- **Primary completion:** 2021-08-31
- **Final completion:** 2021-08-31
- **Target enrollment:** 259 (ACTUAL)
- **Last updated:** 2023-08-16

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03073603

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03073603, "Discontinuation of Disease Modifying Therapies (DMTs) in Multiple Sclerosis (MS)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03073603. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*